Our Research Focus

We are committed to deepening our understanding of obesity through rigorous research and testing.

Current Obesity Treatments

Apart from natural weight loss, GLP-1 Injections have been highly popularized:

Source: Cowen Therapeutics

The drug mimics a natural hormone in our bodies.
Our blood sugars rise after eating, GLP-1 stimulates the body to produce more insulin to lower blood sugar levels.
Blood sugar control is desirable for type II diabetes.

Glucagon-Like Peptide 1 (GLP-1) is a prescription medicine originally used to treat type II diabetes to control blood sugar levels
- The drug mimics a natural hormone in our bodies.
- Our blood sugars rise after eating, GLP-1 stimulates the body to produce more insulin to lower blood sugar levels.
- Blood sugar control is desirable for type II diabetes.
GLP-1 has been approved by the US FDA for the management of obesity.
- The drug seems to curb hunger.
- It also slows down metabolic processes (food movement from stomach to intestines), resulting in us feeling full and eating less. There is also emerging evidence of the benefits of GLP-1 medicine on Obesity related co-morbidities .
- However, 40-60% of the weight lost is what is termed fat free mass. This is predominantly muscle.
It's effect on obesity has been popularized on social media for weight-loss effects, however its long-term effects on muscle loss still needs to be elucidated.

Limitation due to route of administration
- Limits access
Side Effects:
- Nausea
- Vomiting
- Diarrhea
- Potential hypoglycemia
- Professionals are still researching long-term side effects
Muscle Mass Loss: A significant concern impacting overall health
- Reportedly, up to 40-50% of the total amount of the fat free mass could be muscle